News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cohen Fred E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 05/26/2023 |
4
| Cohen Fred E (Director) has filed a Form 4 on Progyny, Inc.|
Txns:
| Granted 4,385 shares
@ $0
Granted 18,350 options to buy
@ $38.24, valued at
$701.7k
|
|
| 01/09/2023 |
4
| Cohen Fred E (Director) has filed a Form 4 on CareDx, Inc.|
Txns:
| Granted 1,062 shares
@ $0 |
|
| 10/26/2022 |
4
| Cohen Fred E (Director) has filed a Form 4 on Progyny, Inc.|
Txns:
| Granted 3,480 shares
@ $0
Granted 15,660 options to buy
@ $38.22, valued at
$598.5k
Granted 1,460 options to buy
@ $38.22, valued at
$55.8k
|
|
| 10/04/2022 |
4
| Cohen Fred E (Director) has filed a Form 4 on CareDx, Inc.|
Txns:
| Granted 803 shares
@ $0 |
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 5,197 shares
@ $0
Granted 7,688 options to buy
@ $38.49, valued at
$295.9k
|
|
| 06/10/2022 |
4
| Cohen Fred E (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $7.06, valued at
$70.6k
|
|
| 10/26/2021 |
4
| Cohen Fred E (Director) has filed a Form 4 on Progyny, Inc.|
Txns:
| Granted 2,652 shares
@ $0
Granted 15,831 options to buy
@ $63.21, valued at
$1M
|
|
| 06/25/2021 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 2,094 shares
@ $0
Granted 3,382 options to buy
@ $83.59, valued at
$282.7k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Cohen Fred E (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $17.98, valued at
$179.8k
|
|
| 01/22/2021 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $13.78, valued at
$275.6k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2020 |
4
| Cohen Fred E (Director) has filed a Form 4 on Progyny, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 27,000 options to buy
@ $27.95, valued at
$754.7k
Granted 894 options to buy
@ $27.95, valued at
$25k
|
|
| 10/20/2020 |
4
| Cohen Fred E (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Exercised 10,000 options to buy
@ $7.6, valued at
$76k
|
|
| 09/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $20.72, valued at
$393.7k
|
|
| 06/10/2020 |
4
| Cohen Fred E (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
| 06/09/2020 |
4
| Cohen Fred E (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 10,000 options to buy
@ $26.3, valued at
$263k
|
|
| 05/19/2020 |
4
| Cohen Fred E (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 35,847 shares
@ $26.7894, valued at
$960.3k
Sold 4,153 shares
@ $27.5068, valued at
$114.2k
|
|
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Exercised 10,000 options to buy
@ $13.19, valued at
$131.9k
Exercised 10,000 options to buy
@ $10.41, valued at
$104.1k
Exercised 10,000 options to buy
@ $5.28, valued at
$52.8k
Exercised 10,000 options to buy
@ $7.94, valued at
$79.4k
|
|
| 07/15/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on CareDx, Inc.|
Txns:
| Exercised 5,255 options to buy
@ $10, valued at
$52.6k
Exercised 5,255 options to buy
@ $5.85, valued at
$30.7k
Exercised 5,255 options to buy
@ $5.02, valued at
$26.4k
|
|
| 07/03/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Granted 212 shares
@ $58.86, valued at
$12.5k
|
|
| 06/19/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on CareDx, Inc.|
Txns:
| Granted 2,613 shares
@ $0
Granted 4,152 options to buy
@ $38.26, valued at
$158.9k
|
|
| 06/18/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Granted 955 shares
@ $0
Granted 6,583 options to buy
@ $52.41, valued at
$345k
|
|
| 06/13/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 10,000 options to buy
@ $27.01, valued at
$270.1k
|
|
| 06/05/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $34.83, valued at
$348.3k
|
|
| 05/22/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $15.78, valued at
$299.8k
|
|
| 04/03/2019 |
4
| Cohen Fred E (Director) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Granted 149 shares
@ $66.84, valued at
$10k
|
|
|
|
|